Newbridge Financial Services Group’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.97K | Hold |
320
| – | – | ﹤0.01% | 998 |
|
|
2025
Q1 | $6.13K | Sell |
320
-240
| -43% | -$4.6K | ﹤0.01% | 764 |
|
|
2024
Q4 | $20.2K | Buy |
+560
| New | +$20.2K | 0.01% | 597 |
|
|
2024
Q3 | – | Sell |
-630
| Closed | -$25.4K | – | 1077 |
|
|
2024
Q2 | $25.4K | Sell |
630
-475
| -43% | -$19.1K | 0.01% | 526 |
|
|
2024
Q1 | $39.1K | Sell |
1,105
-3,365
| -75% | -$119K | 0.02% | 442 |
|
|
2023
Q4 | $132K | Sell |
4,470
-1,555
| -26% | -$46K | 0.06% | 238 |
|
|
2023
Q3 | $125K | Buy |
6,025
+2,615
| +77% | +$54.3K | 0.06% | 255 |
|
|
2023
Q2 | $83.7K | Buy |
3,410
+1,500
| +79% | +$36.8K | 0.04% | 346 |
|
|
2023
Q1 | $77.6K | Buy |
1,910
+500
| +35% | +$20.3K | 0.04% | 363 |
|
|
2022
Q4 | $63.4K | Buy |
1,410
+700
| +99% | +$31.5K | 0.04% | 403 |
|
|
2022
Q3 | $34K | Sell |
710
-41
| -5% | -$1.96K | 0.02% | 560 |
|
|
2022
Q2 | $44K | Hold |
751
| – | – | 0.03% | 434 |
|
|
2022
Q1 | $87K | Sell |
751
-3,429
| -82% | -$397K | 0.04% | 337 |
|
|
2021
Q4 | $629K | Sell |
4,180
-280
| -6% | -$42.1K | 0.3% | 73 |
|
|
2021
Q3 | $532K | Buy |
4,460
+110
| +3% | +$13.1K | 0.33% | 68 |
|
|
2021
Q2 | $424K | Sell |
4,350
-6,926
| -61% | -$675K | 0.26% | 90 |
|
|
2021
Q1 | $995K | Buy |
11,276
+110
| +1% | +$9.71K | 0.73% | 18 |
|
|
2020
Q4 | $1.07M | Buy |
11,166
+221
| +2% | +$21.1K | 0.88% | 13 |
|
|
2020
Q3 | $1.24M | Buy |
+10,945
| New | +$1.24M | 1.22% | 7 |
|